Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 16

1.

Conformational changes and translocation of tissue-transglutaminase to the plasma membranes: role in cancer cell migration.

Kumar A, Hu J, LaVoie HA, Walsh KB, DiPette DJ, Singh US.

BMC Cancer. 2014 Apr 11;14:256. doi: 10.1186/1471-2407-14-256.

PMID:
24725450
[PubMed - in process]
Free PMC Article
2.

Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals.

Osman AM, Al-Harthi SE, AlArabi OM, Elshal MF, Ramadan WS, Alaama MN, Al-Kreathy HM, Damanhouri ZA, Osman OH.

Cancer Cell Int. 2013 May 28;13:52. doi: 10.1186/1475-2867-13-52. eCollection 2013.

PMID:
23714221
[PubMed]
Free PMC Article
3.

Regulatory effects of resveratrol on antioxidant enzymes: a mechanism of growth inhibition and apoptosis induction in cancer cells.

Khan MA, Chen HC, Wan XX, Tania M, Xu AH, Chen FZ, Zhang DZ.

Mol Cells. 2013 Mar;35(3):219-25. doi: 10.1007/s10059-013-2259-z. Epub 2013 Feb 26. Erratum in: Mol Cells. 2013 Apr;35(4):355.

PMID:
23456297
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition.

Quoc Trung L, Espinoza JL, Takami A, Nakao S.

PLoS One. 2013;8(1):e55183. doi: 10.1371/journal.pone.0055183. Epub 2013 Jan 25.

PMID:
23372833
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo.

Lee HS, Ha AW, Kim WK.

Nutr Res Pract. 2012 Aug;6(4):294-300. doi: 10.4162/nrp.2012.6.4.294. Epub 2012 Aug 31.

PMID:
22977682
[PubMed]
Free PMC Article
6.

Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model.

Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM.

Int J Oncol. 2012 Apr;40(4):1277-84. doi: 10.3892/ijo.2011.1316. Epub 2011 Dec 22.

PMID:
22200740
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Optimizing thiadiazole analogues of resveratrol versus three chemopreventive targets.

Mayhoub AS, Marler L, Kondratyuk TP, Park EJ, Pezzuto JM, Cushman M.

Bioorg Med Chem. 2012 Jan 1;20(1):510-20. doi: 10.1016/j.bmc.2011.09.031. Epub 2011 Sep 25.

PMID:
22115839
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy.

Soto BL, Hank JA, Darjatmoko SR, Polans AS, Yanke EM, Rakhmilevich AL, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM.

Int Immunopharmacol. 2011 Nov;11(11):1877-86. doi: 10.1016/j.intimp.2011.07.019. Epub 2011 Aug 18.

PMID:
21854876
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol.

Vang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, Das DK, Delmas D, Gottfried C, Lin HY, Ma QY, Mukhopadhyay P, Nalini N, Pezzuto JM, Richard T, Shukla Y, Surh YJ, Szekeres T, Szkudelski T, Walle T, Wu JM.

PLoS One. 2011;6(6):e19881. doi: 10.1371/journal.pone.0019881. Epub 2011 Jun 16. Review.

PMID:
21698226
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.

Soto BL, Hank JA, Van De Voort TJ, Subramanian L, Polans AS, Rakhmilevich AL, Yang RK, Seo S, Kim K, Reisfeld RA, Gillies SD, Sondel PM.

Cancer Immunol Immunother. 2011 May;60(5):731-8. doi: 10.1007/s00262-011-0971-0. Epub 2011 Feb 22.

PMID:
21340652
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.

Kupisiewicz K, Boissy P, Abdallah BM, Hansen FD, Erben RG, Savouret JF, Søe K, Andersen TL, Plesner T, Delaisse JM.

Calcif Tissue Int. 2010 Nov;87(5):437-49. doi: 10.1007/s00223-010-9399-3. Epub 2010 Sep 15.

PMID:
20842496
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

Hoshino J, Park EJ, Kondratyuk TP, Marler L, Pezzuto JM, van Breemen RB, Mo S, Li Y, Cushman M.

J Med Chem. 2010 Jul 8;53(13):5033-43. doi: 10.1021/jm100274c.

PMID:
20527891
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.

Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S, Aggarwal BB.

Int J Cancer. 2010 Jul 15;127(2):257-68. doi: 10.1002/ijc.25041.

PMID:
19908231
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Design of aging intervention studies: the NIA interventions testing program.

Nadon NL, Strong R, Miller RA, Nelson J, Javors M, Sharp ZD, Peralba JM, Harrison DE.

Age (Dordr). 2008 Dec;30(4):187-99. doi: 10.1007/s11357-008-9048-1. Epub 2008 Apr 18.

PMID:
19424842
[PubMed]
Free PMC Article
15.

Resveratrol in prevention and treatment of common clinical conditions of aging.

Markus MA, Morris BJ.

Clin Interv Aging. 2008;3(2):331-9. Review.

PMID:
18686754
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Resveratrol: a review of preclinical studies for human cancer prevention.

Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL.

Toxicol Appl Pharmacol. 2007 Nov 1;224(3):274-83. Epub 2007 Jan 3. Review.

PMID:
17306316
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk